Advanced search

The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in China

S HU, W CHEN and Lieven Annemans (UGent)
(2004) VALUE IN HEALTH. 7(6). p.686-686
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
HU, S, W CHEN, and Lieven Annemans. 2004. “The Cost-effectiveness of Irbesartan in the Treatment of Hypertensive Type 2 Diabetic Patients with Microalbuminuria in China.” In Value in Health, 7:686–686. BLACKWELL PUBLISHING INC.
APA
HU, S., CHEN, W., & Annemans, L. (2004). The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in China. VALUE IN HEALTH (Vol. 7, pp. 686–686). BLACKWELL PUBLISHING INC.
Vancouver
1.
HU S, CHEN W, Annemans L. The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in China. VALUE IN HEALTH. BLACKWELL PUBLISHING INC; 2004. p. 686–686.
MLA
HU, S, W CHEN, and Lieven Annemans. “The Cost-effectiveness of Irbesartan in the Treatment of Hypertensive Type 2 Diabetic Patients with Microalbuminuria in China.” Value in Health. Vol. 7. BLACKWELL PUBLISHING INC, 2004. 686–686. Print.
@inproceedings{305967,
  author       = {HU, S and CHEN, W and Annemans, Lieven},
  booktitle    = {VALUE IN HEALTH},
  issn         = {1098-3015},
  language     = {eng},
  number       = {6},
  pages        = {686--686},
  publisher    = {BLACKWELL PUBLISHING INC},
  title        = {The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in China},
  volume       = {7},
  year         = {2004},
}

Web of Science
Times cited: